Newsfeeds Archive - Spark Newswire

2 minute read

May 15, 4:30 PM

Celyad Oncology ((Euronext &, NASDAQ:CYAD) (the "Company"), is a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell therapies. The Company had

CYAD

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

May 5, 9:06 AM

Gainers Nanobiotix (NASDAQ:NBTX) stock increased by 125.6% to $4.58 during Friday’s pre-market session. The company’s market cap stands…

ADTX

3 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

April 19, 1:30 PM

Gainers VYNE Therapeutics (NASDAQ:VYNE) stock moved upwards by 38.0% to $4.32 during Wednesday’s regular session. VYNE Therapeutics’s stock…

ALLR

1 minute read

News

Reported Late Tuesday April 4, Celyad Oncology Announces Receipt Of Nasdaq Notice Informing The Company That It Failed To Maintain The Continued Listing Requirement Under Nasdaq Listing Rule 5450(b)(1)(A)

By Happy Mohamed

April 5, 12:32 AM

Celyad Oncology ((Euronext &, NASDAQ:CYAD) (the "Company"), a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell therapies, received a letter (the

CYAD

4 minute read

Earnings

Earnings Scheduled For March 23, 2023

By Benzinga Insights

March 23, 8:10 AM

Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter.

AAMC

3 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

March 15, 1:30 PM

Gainers ThermoGenesis Holdings (NASDAQ:THMO) shares rose 78.7% to $3.77 during Wednesday’s regular session. As of 13:30 EST, this…

BLCM

3 minute read

Why American Public Education Shares Are Trading Lower By Around 49%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

March 15, 1:20 PM

Gainers ThermoGenesis Holdings, Inc. (NASDAQ: THMO) shares jumped 80% to $3.7820 after the company announced the roll out of ReadyStart cGMP Suites for early-stage cell and gene-therapy companies.

$APE

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

February 7, 1:31 PM

Gainers Lixte Biotech Hldgs (NASDAQ:LIXT) shares rose 97.3% to $1.6 during Tuesday’s regular session. Trading volume for this…

CDIO

4 minute read

Celyad Oncology Q4 2022 Business Update And 2023 Outlook; As Of Dec 31, 2022, The Co. Ended The Year With An Unaudited Treasury Position Of $13.3M; Co. Is Now Prioritizing Discovery Endeavors To Tackle The Major Current Limitations Of CAR T-Cell Therap…

By Happy Mohamed

February 3, 2:04 AM

Celyad Oncology has implemented a strategic shift from an organization focused on clinical development to one fully harnessing the true potential of its proprietary technology platforms and intellectual property The

CYAD